About Megaloblastic anemia-immunodeficiency due to folate transporter 1 deficiency
Megaloblastic anemia-immunodeficiency due to folate transporter 1 deficiency is a rare disease catalogued by Orphanet (ORPHA:661412). Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries worldwide.
Clinical Trial Eligibility Tips
What to know before applying to Megaloblastic anemia-immunodeficiency due to folate transporter 1 deficiency trials.
Search ClinicalTrials.gov for "Megaloblastic anemia-immunodeficiency due to folate transporter 1 deficiency" or Orphanet code ORPHA:661412 to find disease-specific recruiting studies.
Ask your specialist to refer you to an Orphanet-accredited Centre of Expertise for this condition.
Natural history studies and patient registries often open enrolment before drug trials — contact the Orphanet patient community first.
Patient Resources
Find recruiting Megaloblastic anemia-immunodeficiency due to folate transporter 1 deficiency trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Megaloblastic anemia-immunodeficiency due to folate transporter 1 deficiency. Updated daily.